Pulse of the Street Relief as Equities Rupee Edge Up but Caution Prevails US Bank Sees Moderate US Economic Growth Path Amid Policy Crosscurrents China Calls for APEC Trade Cooperation as Commerce Minister Skips Opening Due to Urgent Official Business Sebis Digital Bonds Initiative May Deepen Indias Debt Market Benefiting Retail Investors Most Interactive Brokers Gains Recognition as a TopTier Brokerage Amid Impressive Stock Performance Oura Health Files Confidentially for IPO Highlighting Smart Ring Market Growth PAYP Q1 2026 Earnings EPS Misses Estimates by 375 Stock Rises 262 CMMB Q1 2026 Earnings EPS Misses Estimates as Stock Surges on Pipeline Progress Leidos Q1 2026 Earnings EPS Beat with 586 Surprise Shares Rise CDP Q1 2026 Earnings EPS Beats Estimates by 2 Stock Slips Modestly PRH Q1 2026 Earnings Prudential Financial Beats Estimates by 154 but Security Edges Lower INMB Q4 2025 Earnings EPS Beat Surprises as ClinicalStage Biotech Advances Pipeline Knife Riv Holding Co KNF Faces Pressure Key Support Levels Tested After 2 Decline Generac Holdings GNRC Surges 7 as Energy Resilience Demand Gains Momentum Loar Holdings LOAR Advances Modestly as Stock Nears Midpoint of Recent Range Unity Software Holds Steady Near 2557 as Market Weighs Support and Resistance Mosaic MOS Bounces from Support Can the Rally Sustain Federal Reserve Loses Impetus for Rate Cuts Amid Sticky Inflation Youdao DAO Q1 2026 Earnings EPS Misses Estimates but Stock Surges Over 12 Uber Technologies UBER Faces Pressure as Shares Dip to 7259 Testing Key Support Levels BP Ousts Chairman Amid Allegations of Bullying Conduct US Intensifies Efforts to Deploy American AI Across Asia Following TrumpXi Talks Roundhill Memory ETF DRAM Surges to 10 Billion on AIDriven Demand for Memory Chips AGX Files Lawsuit Against RR and Huntington Over Frozen Credit Line and Unpaid Carrier Invoices AMD Announces Over 10 Billion Investment in Taiwans AI Semiconductor Ecosystem Delivery Hero Shares Jump 10 on Reports of Uber Takeover Bid at 33 per Share Oppenheimer Maintains Outperform Rating on Gain Therapeutics Signaling Continued Confidence